Exhaled nitric oxide is associated with inflammatory biomarkers and risk of acute respiratory exacerbations in children with HIV ‐associated chronic lung disease
HIV Medicine · 2024
DOI: 10.1111/hiv.13565 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift HIV Medicine, 2024. Verfasst von Trym Thune Flygel und 10 weiteren Autor:innen. Beteiligte Einrichtung: Paediatric Research Group, Department of Clinical Medicine, Faculty of Health sciences, UiT - The Arctic University of Norway, Tromsø, Norway. Hauptthemen laut MEDLINE: HIV Infections, Lung Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council UK, Norges Forskningsråd.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Objectives
Chronic lung disease is a recognized complication in children with HIV. Acute respiratory exacerbations (ARE) are common among this group and cause significant morbidity. Exhaled nitric oxide (eNO) is a known marker of local airway inflammation. We investigated the association between eNO and ARE, biomarkers of systemic inflammation, and the effect of azithromycin on eNO levels.
Methods
Individuals aged 6–19 years with HIV‐associated chronic lung disease in Harare, Zimbabwe, were enrolled in a placebo‐controlled randomized trial investigating the effect of 48‐week azithromycin treatment on lung function and ARE. eNO levels and biomarkers were measured at inclusion and after treatment in a consecutively enrolled subset of participants. Linear regression and generalized linear models were used to study associations between eNO and ARE, biomarkers, and the effect of azithromycin on eNO levels.
Results
In total, 172 participants were included in this sub‐study, 86 from the placebo group and 86 from the azithromycin group. Participants experiencing at least one ARE during follow‐up had significantly higher eNO levels at baseline than participants who did not (geometric mean ratio 1.13, 95% confidence interval [CI] 1.03–1.24, p = 0.015), adjusted for trial arm, age, sex and history of tuberculosis. Matrix metalloproteinase (MMP)‐3, ‐7, and ‐10 were significantly associated with higher baseline eNO levels. At 48 weeks, azithromycin treatment did not affect eNO levels (geometric mean ratio 0.86, 95% CI 0.72–1.03, p = 0.103).
Conclusion
Higher baseline eNO levels were a risk factor for ARE. eNO was associated with proinflammatory biomarkers previously found to contribute to the development of chronic lung disease. The potential use of eNO as a marker of inflammation and risk factor for ARE in HIV‐associated chronic lung disease needs further investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Paediatric Research Group, Department of Clinical Medicine, Faculty of Health sciences, UiT - The Arctic University of Norway, Tromsø, Norway.
- Department of Paediatrics, University Hospital of North Norway, Tromsø, Norway.
- Nuffield Department of Medicine, University of Oxford, Oxford, UK.
- Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, UK.
- Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.
- Biomedical Research and Training Institute, Harare, Zimbabwe.
Förderung
- Wellcome Trust
- Medical Research Council UK
- Norges Forskningsråd
- Helse Nord RHF
- Medical Research Council
- European Commission
Zitieren
APA
Flygel, T. T., Hameiri-Bowen, D., Simms, V., Rowland-Jones, S., Ferrand, R. A., Bandason, T., Yindom, L. M., Odland, J. Ø., Cavanagh, J. P., Flaegstad, T., & Sovershaeva, E. (2024). Exhaled nitric oxide is associated with inflammatory biomarkers and risk of acute respiratory exacerbations in children with HIV ‐associated chronic lung disease. HIV Medicine. https://doi.org/10.1111/hiv.13565
Vancouver
Flygel TT, Hameiri-Bowen D, Simms V, Rowland-Jones S, Ferrand RA, Bandason T, et al. Exhaled nitric oxide is associated with inflammatory biomarkers and risk of acute respiratory exacerbations in children with HIV ‐associated chronic lung disease. HIV Medicine. 2024. doi:10.1111/hiv.13565
BibTeX
@article{Flygel2024,
author = {Flygel, Trym Thune and Hameiri-Bowen, Dan and Simms, Victoria and Rowland-Jones, Sarah and Ferrand, Rashida Abbas and Bandason, Tsitsi and Yindom, Louis-Marie and Odland, Jon Øyvind and Cavanagh, Jorunn Pauline and Flaegstad, Trond and Sovershaeva, Evgeniya},
title = {Exhaled nitric oxide is associated with inflammatory biomarkers and risk of acute respiratory exacerbations in children with HIV ‐associated chronic lung disease},
journal = {HIV Medicine},
year = {2024},
doi = {10.1111/hiv.13565}
}
EUVIMED